It has been established that TGF-β signaling in the PDAC tumor microenvironment (TME) contributes to the activation of myofibroblast-like CAFs (myCAFs) to foster a more aggressive PDAC phenotype (26–28). This evidence concerns the gene TGFB1 and neoplasm.